Psoriatic Arthritis Therapeutics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Drug Class (Interleukin Inhibitors, PDE4 Inhibitors, TNF Inhibitors, and Other Drug Classes); Route of Administration (Oral, Parenteral and Topical); Distribution Channel (Online Pharmacies, Hospitals Pharmacies and Retail Pharmacies), and Geography
Report Code: TIPRE00004414 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Psoriatic arthritis refers to the type of arthritis, which develops in some people with the skin condition psoriasis. The condition leads to inflammation of joints, causing inflammation, stiffness and pain. Other than inflamed joints, psoriatic arthritis also causes inflammation of the skin. Some of the symptoms of psoriatic arthritis include ankylosing spondylitis, reactive arthritis, and arthritis associated with Crohn's disease and ulcerative colitis.
MARKET DYNAMICS
The psoriatic arthritis therapeutics market is anticipated to grow in the forecast, owing to adoption of biologics for the treatment of psoriatic arthritis and large patient population having unmet medical needs. In addition, the improvement in healthcare facilities offered in the developing economies is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Psoriatic Arthritis Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of psoriatic arthritis therapeutics market with detailed market segmentation by drug class, route of administration, distribution channel, and geography. The global psoriatic arthritis therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading psoriatic arthritis therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global psoriatic arthritis therapeutics market is segmented on the basis of drug class, route of administration and distribution channel. Based on drug class, the market is segmented as, interleukin inhibitors, PDE4 inhibitors, TNF inhibitors, and other drug classes. The psoriatic arthritis therapeutics market is categorized based on route of administration such as oral, parenteral and topical. Similarly, based on distribution channel, the market is categorized such as, online pharmacies, hospitals pharmacies and retail pharmacies.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global psoriatic arthritis therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The psoriatic arthritis therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting psoriatic arthritis therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the psoriatic arthritis therapeutics market in these regions.
MARKET PLAYERS
The reports cover key developments in the psoriatic arthritis therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from psoriatic arthritis therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for psoriatic arthritis therapeutics market in the global market. Below mentioned is the list of few companies engaged in the psoriatic arthritis therapeutics market.
The report also includes the profiles of key psoriatic arthritis therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Psoriatic arthritis refers to the type of arthritis, which develops in some people with the skin condition psoriasis. The condition leads to inflammation of joints, causing inflammation, stiffness and pain. Other than inflamed joints, psoriatic arthritis also causes inflammation of the skin. Some of the symptoms of psoriatic arthritis include ankylosing spondylitis, reactive arthritis, and arthritis associated with Crohn's disease and ulcerative colitis.
MARKET DYNAMICS
The psoriatic arthritis therapeutics market is anticipated to grow in the forecast, owing to adoption of biologics for the treatment of psoriatic arthritis and large patient population having unmet medical needs. In addition, the improvement in healthcare facilities offered in the developing economies is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Psoriatic Arthritis Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of psoriatic arthritis therapeutics market with detailed market segmentation by drug class, route of administration, distribution channel, and geography. The global psoriatic arthritis therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading psoriatic arthritis therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global psoriatic arthritis therapeutics market is segmented on the basis of drug class, route of administration and distribution channel. Based on drug class, the market is segmented as, interleukin inhibitors, PDE4 inhibitors, TNF inhibitors, and other drug classes. The psoriatic arthritis therapeutics market is categorized based on route of administration such as oral, parenteral and topical. Similarly, based on distribution channel, the market is categorized such as, online pharmacies, hospitals pharmacies and retail pharmacies.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global psoriatic arthritis therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The psoriatic arthritis therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting psoriatic arthritis therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the psoriatic arthritis therapeutics market in these regions.
MARKET PLAYERS
The reports cover key developments in the psoriatic arthritis therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from psoriatic arthritis therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for psoriatic arthritis therapeutics market in the global market. Below mentioned is the list of few companies engaged in the psoriatic arthritis therapeutics market.
The report also includes the profiles of key psoriatic arthritis therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AbbVie Inc.
- Amgen Inc.
- Biogen
- Bristol-Myers Squibb Company
- Celgene Corporation
- Eli Lilly and Company
- Janssen Global Services, LLC ((Johnson & Johnson)
- Novartis AG
- Pfizer Inc.
- UCB S.A.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Psoriatic Arthritis Therapeutics Market - By Drug Class
1.3.2 Psoriatic Arthritis Therapeutics Market - By Route of Administration
1.3.3 Psoriatic Arthritis Therapeutics Market - By Distribution Channel
1.3.4 Psoriatic Arthritis Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PSORIATIC ARTHRITIS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PSORIATIC ARTHRITIS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. PSORIATIC ARTHRITIS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. INTERLEUKIN INHIBITORS
7.3.1. Overview
7.3.2. Interleukin Inhibitors Market Forecast and Analysis
7.4. PDE4 INHIBITORS
7.4.1. Overview
7.4.2. PDE4 Inhibitors Market Forecast and Analysis
7.5. TNF INHIBITORS
7.5.1. Overview
7.5.2. TNF Inhibitors Market Forecast and Analysis
7.6. OTHER DRUG CLASSES
7.6.1. Overview
7.6.2. Other Drug Classes Market Forecast and Analysis
8. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. TOPICAL
8.5.1. Overview
8.5.2. Topical Market Forecast and Analysis
9. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. ONLINE PHARMACIES
9.3.1. Overview
9.3.2. Online Pharmacies Market Forecast and Analysis
9.4. HOSPITALS PHARMACIES
9.4.1. Overview
9.4.2. Hospitals Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. PSORIATIC ARTHRITIS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Psoriatic Arthritis Therapeutics Market Overview
10.1.2 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.1.3 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.1.4 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Psoriatic Arthritis Therapeutics Market
10.1.6.1.1 United States Psoriatic Arthritis Therapeutics Market by Drug Class
10.1.6.1.2 United States Psoriatic Arthritis Therapeutics Market by Route of Administration
10.1.6.1.3 United States Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.1.6.2 Canada Psoriatic Arthritis Therapeutics Market
10.1.6.2.1 Canada Psoriatic Arthritis Therapeutics Market by Drug Class
10.1.6.2.2 Canada Psoriatic Arthritis Therapeutics Market by Route of Administration
10.1.6.2.3 Canada Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Psoriatic Arthritis Therapeutics Market
10.1.6.3.1 Mexico Psoriatic Arthritis Therapeutics Market by Drug Class
10.1.6.3.2 Mexico Psoriatic Arthritis Therapeutics Market by Route of Administration
10.1.6.3.3 Mexico Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Psoriatic Arthritis Therapeutics Market Overview
10.2.2 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.2.3 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Psoriatic Arthritis Therapeutics Market
10.2.6.1.1 Germany Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.1.2 Germany Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.1.3 Germany Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2.6.2 France Psoriatic Arthritis Therapeutics Market
10.2.6.2.1 France Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.2.2 France Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.2.3 France Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2.6.3 Italy Psoriatic Arthritis Therapeutics Market
10.2.6.3.1 Italy Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.3.2 Italy Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.3.3 Italy Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2.6.4 Spain Psoriatic Arthritis Therapeutics Market
10.2.6.4.1 Spain Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.4.2 Spain Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.4.3 Spain Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Psoriatic Arthritis Therapeutics Market
10.2.6.5.1 United Kingdom Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.5.2 United Kingdom Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.5.3 United Kingdom Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Overview
10.3.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Psoriatic Arthritis Therapeutics Market
10.3.6.1.1 Australia Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.1.2 Australia Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.1.3 Australia Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3.6.2 China Psoriatic Arthritis Therapeutics Market
10.3.6.2.1 China Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.2.2 China Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.2.3 China Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3.6.3 India Psoriatic Arthritis Therapeutics Market
10.3.6.3.1 India Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.3.2 India Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.3.3 India Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3.6.4 Japan Psoriatic Arthritis Therapeutics Market
10.3.6.4.1 Japan Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.4.2 Japan Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.4.3 Japan Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Psoriatic Arthritis Therapeutics Market
10.3.6.5.1 South Korea Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.5.2 South Korea Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.5.3 South Korea Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Psoriatic Arthritis Therapeutics Market Overview
10.4.2 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Psoriatic Arthritis Therapeutics Market
10.4.6.1.1 South Africa Psoriatic Arthritis Therapeutics Market by Drug Class
10.4.6.1.2 South Africa Psoriatic Arthritis Therapeutics Market by Route of Administration
10.4.6.1.3 South Africa Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Psoriatic Arthritis Therapeutics Market
10.4.6.2.1 Saudi Arabia Psoriatic Arthritis Therapeutics Market by Drug Class
10.4.6.2.2 Saudi Arabia Psoriatic Arthritis Therapeutics Market by Route of Administration
10.4.6.2.3 Saudi Arabia Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Psoriatic Arthritis Therapeutics Market
10.4.6.3.1 U.A.E Psoriatic Arthritis Therapeutics Market by Drug Class
10.4.6.3.2 U.A.E Psoriatic Arthritis Therapeutics Market by Route of Administration
10.4.6.3.3 U.A.E Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Psoriatic Arthritis Therapeutics Market Overview
10.5.2 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Psoriatic Arthritis Therapeutics Market
10.5.6.1.1 Brazil Psoriatic Arthritis Therapeutics Market by Drug Class
10.5.6.1.2 Brazil Psoriatic Arthritis Therapeutics Market by Route of Administration
10.5.6.1.3 Brazil Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Psoriatic Arthritis Therapeutics Market
10.5.6.2.1 Argentina Psoriatic Arthritis Therapeutics Market by Drug Class
10.5.6.2.2 Argentina Psoriatic Arthritis Therapeutics Market by Route of Administration
10.5.6.2.3 Argentina Psoriatic Arthritis Therapeutics Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PSORIATIC ARTHRITIS THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMGEN INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOGEN
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CELGENE CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JANSSEN GLOBAL SERVICES, LLC (JOHNSON & JOHNSON)
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. UCB S.A.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Psoriatic Arthritis Therapeutics Market - By Drug Class
1.3.2 Psoriatic Arthritis Therapeutics Market - By Route of Administration
1.3.3 Psoriatic Arthritis Therapeutics Market - By Distribution Channel
1.3.4 Psoriatic Arthritis Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PSORIATIC ARTHRITIS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PSORIATIC ARTHRITIS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. PSORIATIC ARTHRITIS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. INTERLEUKIN INHIBITORS
7.3.1. Overview
7.3.2. Interleukin Inhibitors Market Forecast and Analysis
7.4. PDE4 INHIBITORS
7.4.1. Overview
7.4.2. PDE4 Inhibitors Market Forecast and Analysis
7.5. TNF INHIBITORS
7.5.1. Overview
7.5.2. TNF Inhibitors Market Forecast and Analysis
7.6. OTHER DRUG CLASSES
7.6.1. Overview
7.6.2. Other Drug Classes Market Forecast and Analysis
8. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. TOPICAL
8.5.1. Overview
8.5.2. Topical Market Forecast and Analysis
9. PSORIATIC ARTHRITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. ONLINE PHARMACIES
9.3.1. Overview
9.3.2. Online Pharmacies Market Forecast and Analysis
9.4. HOSPITALS PHARMACIES
9.4.1. Overview
9.4.2. Hospitals Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. PSORIATIC ARTHRITIS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Psoriatic Arthritis Therapeutics Market Overview
10.1.2 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.1.3 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.1.4 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Psoriatic Arthritis Therapeutics Market
10.1.6.1.1 United States Psoriatic Arthritis Therapeutics Market by Drug Class
10.1.6.1.2 United States Psoriatic Arthritis Therapeutics Market by Route of Administration
10.1.6.1.3 United States Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.1.6.2 Canada Psoriatic Arthritis Therapeutics Market
10.1.6.2.1 Canada Psoriatic Arthritis Therapeutics Market by Drug Class
10.1.6.2.2 Canada Psoriatic Arthritis Therapeutics Market by Route of Administration
10.1.6.2.3 Canada Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Psoriatic Arthritis Therapeutics Market
10.1.6.3.1 Mexico Psoriatic Arthritis Therapeutics Market by Drug Class
10.1.6.3.2 Mexico Psoriatic Arthritis Therapeutics Market by Route of Administration
10.1.6.3.3 Mexico Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Psoriatic Arthritis Therapeutics Market Overview
10.2.2 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.2.3 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Psoriatic Arthritis Therapeutics Market
10.2.6.1.1 Germany Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.1.2 Germany Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.1.3 Germany Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2.6.2 France Psoriatic Arthritis Therapeutics Market
10.2.6.2.1 France Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.2.2 France Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.2.3 France Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2.6.3 Italy Psoriatic Arthritis Therapeutics Market
10.2.6.3.1 Italy Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.3.2 Italy Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.3.3 Italy Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2.6.4 Spain Psoriatic Arthritis Therapeutics Market
10.2.6.4.1 Spain Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.4.2 Spain Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.4.3 Spain Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Psoriatic Arthritis Therapeutics Market
10.2.6.5.1 United Kingdom Psoriatic Arthritis Therapeutics Market by Drug Class
10.2.6.5.2 United Kingdom Psoriatic Arthritis Therapeutics Market by Route of Administration
10.2.6.5.3 United Kingdom Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Overview
10.3.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Psoriatic Arthritis Therapeutics Market
10.3.6.1.1 Australia Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.1.2 Australia Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.1.3 Australia Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3.6.2 China Psoriatic Arthritis Therapeutics Market
10.3.6.2.1 China Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.2.2 China Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.2.3 China Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3.6.3 India Psoriatic Arthritis Therapeutics Market
10.3.6.3.1 India Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.3.2 India Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.3.3 India Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3.6.4 Japan Psoriatic Arthritis Therapeutics Market
10.3.6.4.1 Japan Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.4.2 Japan Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.4.3 Japan Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Psoriatic Arthritis Therapeutics Market
10.3.6.5.1 South Korea Psoriatic Arthritis Therapeutics Market by Drug Class
10.3.6.5.2 South Korea Psoriatic Arthritis Therapeutics Market by Route of Administration
10.3.6.5.3 South Korea Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Psoriatic Arthritis Therapeutics Market Overview
10.4.2 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Psoriatic Arthritis Therapeutics Market
10.4.6.1.1 South Africa Psoriatic Arthritis Therapeutics Market by Drug Class
10.4.6.1.2 South Africa Psoriatic Arthritis Therapeutics Market by Route of Administration
10.4.6.1.3 South Africa Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Psoriatic Arthritis Therapeutics Market
10.4.6.2.1 Saudi Arabia Psoriatic Arthritis Therapeutics Market by Drug Class
10.4.6.2.2 Saudi Arabia Psoriatic Arthritis Therapeutics Market by Route of Administration
10.4.6.2.3 Saudi Arabia Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Psoriatic Arthritis Therapeutics Market
10.4.6.3.1 U.A.E Psoriatic Arthritis Therapeutics Market by Drug Class
10.4.6.3.2 U.A.E Psoriatic Arthritis Therapeutics Market by Route of Administration
10.4.6.3.3 U.A.E Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Psoriatic Arthritis Therapeutics Market Overview
10.5.2 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Psoriatic Arthritis Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Psoriatic Arthritis Therapeutics Market
10.5.6.1.1 Brazil Psoriatic Arthritis Therapeutics Market by Drug Class
10.5.6.1.2 Brazil Psoriatic Arthritis Therapeutics Market by Route of Administration
10.5.6.1.3 Brazil Psoriatic Arthritis Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Psoriatic Arthritis Therapeutics Market
10.5.6.2.1 Argentina Psoriatic Arthritis Therapeutics Market by Drug Class
10.5.6.2.2 Argentina Psoriatic Arthritis Therapeutics Market by Route of Administration
10.5.6.2.3 Argentina Psoriatic Arthritis Therapeutics Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PSORIATIC ARTHRITIS THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMGEN INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOGEN
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CELGENE CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JANSSEN GLOBAL SERVICES, LLC (JOHNSON & JOHNSON)
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. UCB S.A.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. AbbVie Inc.
2. Amgen Inc.
3. Biogen
4. Bristol-Myers Squibb Company
5. Celgene Corporation
6. Eli Lilly and Company
7. Janssen Global Services, LLC ((Johnson & Johnson)
8. Novartis AG
9. Pfizer Inc.
10. UCB S. A.
1. AbbVie Inc.
2. Amgen Inc.
3. Biogen
4. Bristol-Myers Squibb Company
5. Celgene Corporation
6. Eli Lilly and Company
7. Janssen Global Services, LLC ((Johnson & Johnson)
8. Novartis AG
9. Pfizer Inc.
10. UCB S. A.